Customer Care Tel: 0161 483 5884
Email: ukcustomer@alere.com
Website: www.alere.co.uk
Connecting withEmergency Medicine
Biomarkers in Acute Kidney Injury (AKI) Conference Report
The current status of the endogenous biomarker Neutrophil Gelatinase-Associated Lipocalin (NGAL) and its role in predicting renal injury in various clinical situations was addressed at the Scientific Symposium on Biomarkers in Acute Kidney Injury, which was chaired by two highly renowned experts.
The symposium reviewed our current understanding of Acute Kidney Injury (AKI) and the Cardio-Renal Syndrome (CRS), and summarized the current potential utility of NGAL in predicting AKI in the clinical settings of the Emergency Department (ED), heart dysfunction, interventional cardiology and the Intensive Care Unit (ICU). The expanding role of NGAL and its potential future applications was also touched on. This review highlights key information from the symposium.
To obtain your free copy of the full review paper click the enquire button on the left
(please ensure you include a full postal address)
Biomarkers in Acute Kidney Injury (AKI) Conference report from the scientific symposium held in Prague
Co-Chairmen: Professor Claudio Ronco and Professor Christian Muller
The current status of the endogenous biomarker Neutrophil Gelatinase-Associated Lipocalin (NGAL) and its role in predicting renal injury in various clinical situations was addressed at the Scientific Symposium on Biomarkers in Acute Kidney Injury, which was chaired by two highly renowned experts: Prof. Claudio Ronco, a nephrologist specializing in both adult and pediatric nephrology from St. Bortolo Hospital in Vicenza, Italy, and Prof. Christian Muller, a cardiologist, intensive care specialist and internist from the University of Basel, Switzerland. The expert speakers included additional specialists in the fields of anesthesiology,critical care medicine, emergency medicine, transplantation and epidemiology.
The symposium reviewed our current understanding of Acute Kidney Injury (AKI) and the Cardio-Renal Syndrome (CRS), and summarized the current potential utility of NGAL in predicting AKI in the clinical settings of the Emergency Department (ED), heart dysfunction, interventional cardiology and the Intensive Care Unit (ICU). The expanding role of NGAL and its potential future applications was also touched on. This review highlights key information from the symposium.
To obtain your free copy of the full review paper click the enquire button on the left (please ensure you include a full postal address)